Skip to main content

Table 2 Univariate and multivariate analyses to identified factors predicting severe PHLF

From: Impact of aspartate aminotransferase–to–platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma

Variables Odds ratio 95% CI P value Odds ratio 95% CI P value
PALBI 6.98 2.07–23.6 0.0021* 3.81 0.65–22.3 0.1385
FIB-4 index 1.03 0.99–1.06 0.1674    
APRI 1.36 1.15–1.62 0.0009** 1.32 1.05–1.65 0.0230*
ALPlat index 0.99 0.98–0.99 0.0106* 0.99 0.99–1.00 0.9852
ICG-R15 (%) 1.05 1.01–1.08 0.0070* 1.02 0.97–1.06 0.4890
MELD score 1.43 1.221.68 < 0.0001** 1.44 1.15–1.80 0.0020*
Operating time (min) 1.01 1.00–1.01 < 0.0001** 1.01 1.00–1.01 0.0019*
Intraoperative blood loss (mL) 1.00 1.00–1.00 < 0.0001** 1.00 1.00–1.00 0.0278*
  1. ALPlat index platelet count + 90 × albumin, APRI AST-to-platelet ratio index, AST asparate aminotransferase, CI confidence interval, FIB-4 fibrosis-4, ICG-R15 indocyanine green dye retention rate at 15 min, MELD model for end-stage liver disease, PALBI platelet-albumin-bilirubin, PHLF posthepatectomy liver failure *P < 0.05 and **P < 0.001